Human Immunodeficiency Virus  >>  aldoxorubicin (INNO-206)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
aldoxorubicin (INNO-206) / LadRx
NCT02029430: A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma

Completed
2
15
US
50 mg/m2 aldoxorubicin, 100 mg/m2 aldoxorubicin, 150 mg/m2 aldoxorubicin
ImmunityBio, Inc.
Kaposi's Sarcoma, HIV Positive, AIDS
04/16
04/16

Download Options